Josh Gottheimer sold REGN on February 8, 2024 | PolitAlpha
Josh Gottheimer sold REGN (Regeneron Pharmaceuticals Inc) on Feb 8, 2024 with an estimated value between $1,000 and $15,000. This trade was filed under joint. The stock is currently down 32.5% from the trade price.